logo
PROVIDERS
LABS
CROs
PAYORS
PATIENTS
ABOUT US
Schedule a Demo
Contact Us
Providers Endocrinology
scientists image
Overview

Elevate Endocrine Care with Precision Pharmacogenomics

Personalize treatments for diabetes, thyroid disorders, and beyond—reducing complications and boosting patient outcomes across your health system.
Schedule a Demo Contact us
Overview
Hormonal and metabolic disorders require carefully tailored therapies due to the delicate balance of hormones and the potential for varied patient responses. PGxAI’s Endocrinology module (PGxHorme™) integrates advanced pharmacogenomics and real-world data to help endocrinologists optimize treatments for diabetes, thyroid dysfunctions, bone health, and more. By aligning each patient’s genetic profile with the right medication and dosage, PGxHorme™ reduces adverse effects, improves glycemic control, and enhances long-term quality of life.
•
50+ endocrine therapies covered, including oral hypoglycemics, insulin, thyroid meds, and hormonal supplements.
•
35 critical genetic markers analyzed for drug metabolism and responsiveness.
•
AI-driven insights updated in real time, minimizing trial-and-error and improving clinical outcomes.
Key Highlights
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
1
icon
Comprehensive Drug-Gene Analysis
Guides selection of Metformin, GLP-1 agonists, thyroid hormones, and other endocrine agents based on each patient’s genetic makeup.
2
icon
Improved Glycemic Control
Personalized dosing strategies reduce hypoglycemic events and optimize A1C levels in diabetic patients.
3
icon
Reduced Hormonal Imbalances
Genetic markers help tailor therapies for thyroid disorders and hormonal replacement, minimizing overtreatment or undertreatment.
4
icon
EHR-Integrated Workflows
PGxHorme™ works seamlessly within leading EHR systems, providing instant alerts and dosage recommendations in your existing clinical interface.
5
icon
Reimbursement Pathways
Supported by standard CPT codes, making personalized endocrinology both clinically effective and financially sustainable.
Clinical Impact
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
Decreased Complications
Better-tailored diabetic regimens and thyroid treatments minimize ER visits for hypoglycemia or severe hormonal fluctuations.
Enhance Patient Satisfaction
Patients experience fewer side effects and more rapid therapeutic responses, fostering trust in their oncology care team.
Streamlined Clinical Efficiency
Automatic PGx alerts save time for endocrinologists and pharmacists, reducing repeated dose adjustments and lab work.
Aligned with Value-Based Care
Lower complication rates and improved patient-reported outcomes can enhance quality scores and drive reimbursement benefits.
Drug Categories
PGxAI supports a wide range of endocrine therapies
Schedule a Demo Contact Us
Oral Hypoglycemics:
Metformin, Sulfonylureas, DPP-4 Inhibitors (e.g., Sitagliptin)
GLP-1 Agonists:
Liraglutide, Semaglutide
Insulin & Analogues:
Regular Insulin, Insulin Glargine, Lispro
Thyroid Medications:
Levothyroxine, Methimazole, Liothyronine
Bone Health:
Bisphosphonates (Alendronate), Vitamin D, Calcium Supplements. Each recommendation is derived from validated genetic data (e.g., CYP2C9, TSH receptor variants) and real-world clinical outcomes.
Integration
Seamless EHR Integration
PGxHorme™ is built for scalable deployment across health systems:
icon
Security
HIPAA & SOC 2 compliance ensures patient privacy and data integrity.
icon
Automations
Automated alerts for high-risk gene-drug interactions.
icon
Analytics
Customizable dashboards for oncology pharmacists, oncologists, and care coordinators.
Case Study
Riverside Endocrine Center
Schedule a Demo Contact Us
icon
Challenge
High rates of toxic side effects in metastatic breast cancer patients on combination chemotherapy, leading to repeated ED visits.
icon
Solution
PGxHorme™ integrated to identify optimal dosing regimens and recommended alternative agents for genetically at-risk patients.
icon
Results
40% reduction in severe hypoglycemic incidents within 6 months, improved glycemic control, and increased patient satisfaction.
“PGxAI allowed us to refine dosing protocols for our diabetes population, leading to fewer dangerous episodes and better quality of life for patients.”
human image
Dr. Lisa Everett
Lead Endocrinologist, Riverside Endocrine
Whats next
Ready to Shape the Future of Precision Medicine?
Empower your endocrine teams with data-driven pharmacogenomics that streamline therapy selection, reduce complications, and drive better patient outcomes.
Contact Our Endocrinology Team
Discuss pilot programs and seamless EHR integration.
icon
Request a Demo
See how PGxHorme™ can elevate your endocrine workflows.
icon
Learn More About EHR Integration
Explore secure, scalable interoperability solutions.
icon